Stay updated on Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the previous study details and links with an error message. This indicates the record is currently inaccessible and removes access to the study information.
    Difference
    18%
    Check dated 2026-09-19T19:30:25.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    NIH funding reference for 2018 was added to the funding information. A new publication citation by Sathe et al. on Sacituzumab Govitecan pharmacokinetics was added to the Publications/IPD section, and the revision tag was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T20:10:41.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.5 replacing v3.6.4. This indicates a minor update to the page’s revision, likely affecting internal documents or UI rather than the study content.
    Difference
    0.0%
    Check dated 2026-08-08T10:38:39.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page now displays a new revision tag Revision: v3.6.4, replacing the previous v3.6.3. This indicates an internal version update that does not alter the study content or user-facing data.
    Difference
    0.0%
    Check dated 2026-07-25T05:38:13.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor documentation update.
    Difference
    0.0%
    Check dated 2026-07-03T21:46:24.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page's revision line changed from Revision: v3.6.0 to Revision: v3.6.2. This update indicates a newer build of the Study Details page.
    Difference
    0.0%
    Check dated 2026-06-26T23:53:36.000Z thumbnail image

Stay in the know with updates to Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page.